Special considerations of care and risk management for African American patients with type 2 diabetes mellitus

Journal of the National Medical Association

Volumn 104, Issue 5-6, 2012, Pages 265-273

  Kountz, David ^a,b  

^a JERSEY SHORE UNIVERSITY MEDICAL CENTER   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

African Americans; Diabetes mellitus; Risk factors

Indexed keywords

ALBUMIN; ALCOHOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DULOXETINE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTEIN; SATURATED FATTY ACID; SODIUM; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; TRANS FATTY ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

AEROBIC EXERCISE; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ANALGESIA; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; AUTONOMIC NEUROPATHY; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTONOMIC NEUROPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); COUGHING; CREATINE KINASE BLOOD LEVEL; DIABETES EDUCATION; DIABETIC DYSLIPIDEMIA; DIABETIC MACULAR EDEMA; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DIETARY FIBER; DISEASE ASSOCIATION; DISTAL SYMMETRIC POLYNEUROPATHY; DIURETIC THERAPY; DRUG EFFECT; DRUG INFORMATION; DRUG RESPONSE; DRUG SAFETY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; EYE EXAMINATION; FOOT; FRUIT; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEMOGLOBINOPATHY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY FUNCTION; LASER COAGULATION; LIFESTYLE MODIFICATION; LOW FAT DIET; MONOTHERAPY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL REQUIREMENT; OBESITY; PATIENT CARE; PATIENT COUNSELING; PATIENT REFERRAL; PERIODIC MEDICAL EXAMINATION; PERIPHERAL NEUROPATHY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEIN URINE LEVEL; PUBLIC HEALTH SERVICE; RACISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIGION; RESISTANCE TRAINING; REVIEW; RISK MANAGEMENT; RISK REDUCTION; SEX RATIO; SMOKING CESSATION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; VEGETABLE; WEIGHT REDUCTION;

EID: 84865406710     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30158-9     Document Type: Article

References (66)

1. Cheung BMY, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443-453.
2. American Diabetes Association. African Americans and Complications. www.diabetes.org/living-with-diabetes/complications/african-americans-and- complications.html.
3. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: United States, 2005-2050. Diabetes Care. 2006;29(9):2114-2116.
4. Marshall MC Jr. Diabetes in African Americans. Postgrad Med J. 2005;81(962):734-740.
5. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.
6. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. Hyattsville, MD: National Center for Health Statistics; May 2010.
7. Orsi JM, Margellos-Anast H, Whitman S. Black-White health disparities in the United States and Chicago: a 15-year progress analysis. Am J Public Health. 2010;100(2):349-356.
8. Umpierrez GE. Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care. 2006;29(12):2755-2757.
9. Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006;144(5):350-357.
10. Marshall MC Jr. Overcoming barriers to glycemic control in African Americans with type-2 diabetes: benefits of insulin therapy. J Natl Med Assoc. 2007;99(8):868-875.
11. Banerji MA. Diabetes in African Americans: unique pathophysiologic features. Curr Diab Rep. 2004;4(3):219-223.
12. National Cholesterol Education Program. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
13. AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13 (suppl 1):1-68.
14. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
15. The Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566-1575.
16. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3):235-241.
17. Kramer H, Cao G, Dugas L, Luke A, Cooper R, Durazo-Arvizu R. Increasing BMI and waist circumference and prevalence of obesity among adults with type 2 diabetes: the National Health and Nutrition Examination Surveys. J Diabetes Complications. 2010;24(6):368-374.
18. Sondik EJ, Madans JH, Gentleman JF. Summary health statistics for U.S. adults: National Health Interview Survey, 2009. National Center for Health Statistics. Vital and Health Statistics. 2010;10 (249).
19. Schisler JC, Charles PC, Parker JS, et al. Stable patterns of gene expression regulating carbohydrate metabolism determined by geographic ancestry. PLoS One. 2009;4(12):e8183.
20. Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care. 2004;27(8):2067-2073.
21. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, blackwhite differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770-777.
22. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47(2):153-163.
23. National Diabetes Information Clearinghouse. Sickle cell trait and other hemoglobinopathies and diabetes: Important information for physicians. Bethesda, MD: National Institutes of Health; 2008. NIH publication 09-6287. http://diabetes.niddk.nih.gov/dm/pubs/hemovari-A1C/SickleCell-Fact.pdf.
24. 1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29(9):2130-2136.
25. Wendel CS, Shah JH, Duckworth WC, Hoffman RM, Mohler MJ, Murata GH. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study. BMC Health Serv Res. 2006;6:58.
26. Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Med Care. 2010;48(6):527-533.
27. Saydah S, Cowie C, Eberhardt MS, De Rekeneire N, Narayan KM. Race and ethnic differences in glycemic control among adults with diagnosed diabetes in the United States. Ethn Dis. 2007;17(3):529-535.
28. Svensson CK. Representation of American blacks in clinical trials of new drugs. JAMA. 1989;261(2):263-265.
29. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
30. Suh DC, Kim CM, Choi IS, Plauschinat CA, Barone JA. Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988-2004. J Hypertens. 2009;27(9):1908-1916.
31. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
32. Law CM, Shiell AW. Is blood pressure inversely related to birth weight? The strength of evidence from a systematic review of the literature. J Hypertens. 1996;14(8):935-941.
33. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in blacks. An update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56(5):780-800.
34. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60(1):8-13.
35. Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol. 2007;6(2):67-71.
36. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150-159.
37. McKenney JM, Davidson MH, Jacobson TA, Guyton JR. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol. 2006;97(8A):89C-94C.
38. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2)(suppl 2):S12-S154.
39. Centers for Disease Control and Prevention. Age-adjusted incidence of end-stage renal disease related to diabetes mellitus (ESRD-DM) per 100,000 diabetic population, by race/ethnicity and sex, United States, 1980-2006. www.cdc.gov/diabetes/statistics/esrd/fig5.htm. Accessed October 28, 2010.
40. Lopes AA. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis. Spring 2009;19(1) (suppl 1):S1-47-51.
41. Emanuele N, Moritz T, Klein R, et al. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract. 2009;86(2):104-110.
42. Emanuele N, Sacks J, Klein R, et al. Ethnicity, race, and baseline retinopathy correlates in the Veterans Affairs Diabetes Trial. Diabetes Care. 2005;28(8):1954-1958.
43. Sosenko JM. The prevalence of diabetic neuropathy according to ethnicity. Curr Diab Rep. 2009;9(6):435-439.
44. American Diabetes Association. Executive summary: Standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(suppl 1):S4-S10.
45. Gavin JR III, Wright EE Jr. Building cultural competency for improved diabetes care: African Americans and diabetes. J Fam Pract. 2007;56(9)(suppl building):S22-S28.
46. Dodani S, Fields JZ. Implementation of the fit body and soul, a church-based life style program for diabetes prevention in high-risk African Americans: a feasibility study. Diabetes Educ. 2010;36(3):465-472.
47. Samuel-Hodge CD, Keyserling TC, France R, et al. A church-based diabetes self-management education program for African Americans with type 2 diabetes. Prev Chronic Dis. 2006;3(3):A93.
48. Samuel-Hodge CD, Keyserling TC, Park S, Johnston LF, Gizlice Z, Bangdiwala SI. A randomized trial of a church-based diabetes self-management program for African Americans with type 2 diabetes. Diabetes Educ. 2009;35(3):439-454.
49. Faridi Z, Shuval K, Njike VY, et al. Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches. Health Educ Res. 2010;25(2):306-315.
50. Vachon GC, Ezike N, Brown-Walker M, Chhay V, Pikelny I, Pendergraft TB. Improving access to diabetes care in an inner-city, community-based outpatient health center with a monthly open-access, multistation group visit program. J Natl Med Assoc. 2007;99(12):1327-1336.
51. Two Feathers J, Kieffer EC, Palmisano G, et al. Racial and Ethnic Approaches to Community Health (REACH) Detroit partnership: improving diabetes-related outcomes among African American and Latino adults. Am J Public Health. 2005;95(9):1552-1560.
52. Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853-1860.
53. Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in longterm adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24.
54. Misra R, Lager J. Ethnic and gender differences in psychosocial factors, glycemic control, and quality of life among adult type 2 diabetic patients. J Diabetes Complications. 2009;23(1):54-64.
55. Williams DR, Rucker TD. Understanding and addressing racial disparities in health care. Health Care Financ Rev. 2000;21(4):75-90.
56. Kirk JK, Graves DE, Bell RA, Hildebrandt CA, Narayan KM. Racial andethnic disparities in self-monitoring of blood glucose among US adults: a qualitative review. Ethn Dis. 2007;17(1):135-142.
57. Dagogo-Jack S, Funnell MM, Davidson J. Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focus. Curr Diabetes Rev. 2006;2(3):285-293.
58. Levine DA, Allison JJ, Cherrington A, Richman J, Scarinci IC, Houston TK. Disparities in self-monitoring of blood glucose among low-income ethnic minority populations with diabetes, United States. Ethn Dis. 2009;19(2):97-103.
59. Shacter HE, Shea JA, Akhabue E, Sablani N, Long JA. A qualitative evaluation of racial disparities in glucose control. Ethn Dis. 2009;19(2):121-127.
60. Hsu WC, Yoon HH, Gavin JR III, Wright EE Jr, Cabellero AE, Tenzer P. Building cultural competency for improved diabetes care: Introduction and Overview. J Fam Pract. 2007;56(9)(suppl building):S11-S14.
61. Tripp-Reimer T, Choi E, Skemp Kelley LS, Enslein JC. Cultural barriers to care: inverting the problem. Diabetes Spectrum. 2001;14(1):13-22.
62. Peek ME, Tang H, Alexander GC, Chin MH. National prevalence of lifestyle counseling or referral among African-Americans and whites with diabetes. J Gen Intern Med. 2008;23(11):1858-1864.
63. Rhee MK, Ziemer DC, Caudle J, Kolm P, Phillips LS. Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ. 2008;34(4):655-663.
64. Brown AF, Gregg EW, Stevens MR, et al. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2005;28(12):2864-2870.
65. Evelyn B, Toigo T, Banks D, et al. Participation of racial/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999. J Natl Med Assoc. 2001;93(12)(suppl):18S-24S.
66. Shaya FT, Gbarayor CM, Huiwen Keri Y, Agyeman-Duah M, Saunders E. A perspective on African American participation in clinical trials. Contemp Clin Trials. 2007;28(2):213-217.